Clarity fuel
posted on
Abbott and J&J to duke it out in court over a patent dispute on new rheumatoid arthritis drug. Amylin eliminating 200 sales positions - Drugmaker Amylin Pharmaceuticals Inc. said Monday it will …
Continue Reading about Today’s Top Three in Pharma Cinco de Mayo →
posted on
Ortho-McNeil launches Facebook page for adult ADHD sufferers. Lilly and Amylin teaming up to produce once-a-week diabetes pen. Good stuff on Merck KGaA's oral MS drug. That company and Novartis both …
posted on
When placebos outperform CNS drugs - an interesting article on Seeking Alpha. Afinitor - new cancer blockbuster for Novartis? - Novartis AG’s cancer pill Afinitor, approved yesterday by U.S. …
posted on
Farewell, DNA - the Roche takeover of Genentech is a done deal. What will this do to the culture of both companies, I wonder? DiabetesTV? Forbes explains. Good news for Amylin and Eli Lilly on …
posted on
Avastin + Tarceva = better results in lung cancer - Genentech said the trial was stopped early after an interim analysis found that combining Avastin, known generically as bevacizumab, and Tarceva, or …
posted on
Astellas makes a big to acquire CV Therapeutics. Japan's Astellas Pharma is offering a billion dollars in cash for CV Therapeutics. The bid comes in at $16 a share, a whopping 41 percent premium over …